hotspot -WSS

hotspot

author：hotspot 2025-09-30 02:15:25 - browse：2749

Surrounded by tablets, an elder miniature figure walks with a cane next to a stethoscope — coverage from STAT — Adobe

Medicare Advantage is arguably the most controversial health care program right now — a sentiment that was bolstered Friday by striking new data about overpayments and an uncommon political jab during a routine meeting of policy wonks.

The Medicare Payment Advisory Commission, a group that advises Congress on Medicare policy, gathered to discuss its pending March report on the state of Medicare Advantage, the alternative to traditional Medicare that is run by health insurance companies. Medicare Advantage is expected to cost taxpayers $507 billion this year, according to the latest federal estimates.

The group, known as MedPAC, came to several familiar conclusions from the staff’s presentation and report: The federal government significantly overpays Medicare Advantage insurers because they attract healthier, lower-cost people into their plans and then excessively code those people’s health conditions — making Medicare Advantage a drain on taxpayers. MedPAC’s staffers also reiterated that Medicare Advantage’s quality rating system is “not a good basis for judging quality,” and therefore leads to further overpayments because insurers are paid bonuses based on this quality system.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： New Covid vaccine is recommended for everyone 6 months or older

hotspot

WSS

European officials brace for rough respiratory virus season

How to make the FDA’s new prescription one

IRA could hurt research into orphan drugs for rare diseases

New oral drug delivery patch is modeled after octopus tentacles

Medicare innovation center doesn’t save money, experts say

New Covid vaccine is recommended for everyone 6 months or older

hotspot

hotspot

focus

Apple is now the first public company to be valued at $3 trillion

White House touts steps to stem shortages of cancer treatments

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The United States is paying nearly triple for new Covid vaccines

ChatGPT in medicine: STAT answers readers' burning questions

How medical schools plan to diversify without affirmative action

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

FDA panel endorses Alnylam’s heart drug — after picking it apart

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Private equity could exacerbate cardiology's overuse problem, experts fear

hotspot

Private equity could exacerbate cardiology's overuse problem, experts fear

Hospitals consider fixing cancer drug shortages on their own

Private equity could exacerbate cardiology's overuse problem, experts fear

Long Covid needs a new name — and a new frame

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

IRA could hurt research into orphan drugs for rare diseases

Wikipedia

hotspot

hotspot

Wikipedia